Literature DB >> 92670

Comparison of hormonal and metabolic effects of salbutamol infusion in normal subjects and insulin-requiring diabetics.

A S Gündogdu, P M Brown, S Juul, L Sachs, P H Sönksen.   

Abstract

A comparison of the metabolic effects of salbutamol in diabetic patients and normal subjects showed that salbutamol infused at 5 and 2 microgram/min (a) stimulated hepatic glucose production to a greater extent in diabetic patients than in normal subjects despite prior restoration of the diabetic patients' fasting blood glucose to normal by an overnight infusion of insulin; (b) caused a greater rise in plasma glucose, free fatty acids, glycerol, and ketone-body concentrations in the diabetic patients; and (c) produced a marked fall in plasma-potassium concentrations. The differences between the diabetic and normal groups were accounted for by an immediate (six-fold) stimulation of insulin secretion in the normal subjects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92670     DOI: 10.1016/s0140-6736(79)92810-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man.

Authors:  S Raptis; J Rosenthal; D Welzel; S Moulopoulos
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 3.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

4.  Hypokalaemia due to salbutamol overdosage.

Authors:  I A O'Brien; J Fitzgerald-Fraser; I G Lewin; R J Corrall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

5.  Beta-adrenergic blockade restores glucose's antiketogenic activity after exercise in carbohydrate-depleted athletes.

Authors:  J H Adams; G Irving; J H Koeslag; J D Lochner; R C Sandell; C Wilkinson
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182

6.  Effects of beta non-selective and beta 1 selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas.

Authors:  F Gregorio; P Filipponi; S Cristallini; C Carloni; I Moretti; C Ferrandina; R Pippi; M Pietropaolo
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

7.  Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.

Authors:  C Tantucci; F Santeusanio; M Beschi; M Castellano; C Sorbini; V Grassi
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

8.  A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.

Authors:  J Saunders; R Gomeni; J R Kilborn; P L Morselli; P H Sönksen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 10.  Adverse reactions to beta 2-agonist bronchodilators.

Authors:  K M Lulich; R G Goldie; G Ryan; J W Paterson
Journal:  Med Toxicol       Date:  1986 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.